Skip to main content
. 2011 Apr;13(4):457–460. doi: 10.1089/dia.2010.0159

FIG. 1.

FIG. 1.

Changes in clinical parameters from time of study enrollment to end of optimization period for each subject. (A) Improved hemoglobin A1c was achieved via redistribution of basal insulin doses (significantly decreased, P = 0.01) and prandial doses (slightly increased, P = 0.07). (B) Body weight increased by more than 1 kg in only three subjects.